Michael D. Toboni

Oncology

619 19th St S
Birmingham, AL 35249

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer.

Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer.

Journal: JAMA network open

Published: August 10, 2026

A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.

A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.

Journal: Gynecologic oncology

Published: April 13, 2026

High-volume mucinous ascites secondary to low-grade mucinous neoplasm arising in a mature cystic teratoma: a case report.

High-volume mucinous ascites secondary to low-grade mucinous neoplasm arising in a mature cystic teratoma: a case report.

Journal: AME case reports

Published: January 29, 2026

Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.

Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.

Journal: Molecular cancer research : MCR

Published: January 20, 2026

Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.

Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.

Journal: JCO precision oncology

Published: September 24, 2025

Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

Journal: Gynecologic oncology

Published: August 25, 2025

Approaches to optimize the benefits of immunotherapy and immunotherapy combinations across endometrial cancer types.

Approaches to optimize the benefits of immunotherapy and immunotherapy combinations across endometrial cancer types.

Journal: Journal of the National Cancer Institute

Published: August 13, 2025

The use of transrectal ultrasound to improve gynecologic interstitial applicator implantation.

The use of transrectal ultrasound to improve gynecologic interstitial applicator implantation.

Journal: Gynecologic oncology

Published: May 26, 2025

AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancer.

AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancer.

Journal: Gynecologic oncology

Published: May 20, 2025

Venous thromboembolism risk for patients with BMI ≥40 kg/m2 undergoing robotic surgery for endometrial cancer.

Venous thromboembolism risk for patients with BMI ≥40 kg/m2 undergoing robotic surgery for endometrial cancer.

Journal: Gynecologic oncology reports

Published: April 23, 2025

Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019.

Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019.

Journal: Gynecologic oncology

Published: March 19, 2025

Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.

Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 07, 2025

Showing 1-12 of 31

Last Updated: 09/26/2026